Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30352% above fair value
$14.98+0.18 (+1.22%)
Close on Nov 18, 2026Market cap $1.60BP/E –Yield –
Personalis net income
Net income is the profit left for shareholders after every expense, interest and tax.
Personalis's net income for the twelve months ending Jun 30, 2026 was -$107.18M. For fiscal 2025 it was -$81.27M. The highest annual figure on record is -$19.89M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$81.27M | – |
| FY2024 | Dec 31, 2024 | -$81.28M | – |
| FY2023 | Dec 31, 2023 | -$108.30M | – |
| FY2022 | Dec 31, 2022 | -$113.32M | – |
| FY2021 | Dec 31, 2021 | -$65.23M | – |
| FY2020 | Dec 31, 2020 | -$41.28M | – |
| FY2019 | Dec 31, 2019 | -$25.08M | – |
| FY2018 | Dec 31, 2018 | -$19.89M | – |
| FY2017 | Dec 31, 2017 | -$23.60M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$31.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$30.03M | – |
| Q4 FY2025 | Dec 31, 2025 | -$23.81M | – |
| Q3 FY2025 | Sep 30, 2025 | -$21.65M | – |
| Q2 FY2025 | Jun 30, 2025 | -$20.06M | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.75M | – |
| Q4 FY2024 | Dec 31, 2024 | -$16.43M | – |
| Q3 FY2024 | Sep 30, 2024 | -$39.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.80M | – |
| Q1 FY2024 | Mar 31, 2024 | -$12.97M | – |
| Q4 FY2023 | Dec 31, 2023 | -$26.58M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.10M | – |
| Q2 FY2023 | Jun 30, 2023 | -$23.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$28.66M | – |
| Q4 FY2022 | Dec 31, 2022 | -$31.07M | – |
| Q3 FY2022 | Sep 30, 2022 | -$26.49M | – |
| Q2 FY2022 | Jun 30, 2022 | -$27.55M | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.21M | – |
| Q4 FY2021 | Dec 31, 2021 | -$20.20M | – |
| Q3 FY2021 | Sep 30, 2021 | -$17.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.95M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.40M | – |
| Q4 FY2020 | Dec 31, 2020 | -$13.34M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.14M | – |
| Q4 FY2019 | Dec 31, 2019 | -$6.65M | – |
| Q3 FY2019 | Sep 30, 2019 | -$6.89M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.87M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.69M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.56M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.64M | – |
| Q2 FY2018 | Jun 30, 2018 | -$7.32M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.38M | – |
See a number that looks wrong?